306 assets in B-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing B-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
cd22 car-t B-Cell Non-Hodgkin Lymphoma	Rong Tao	P1	CCC (50)
hem101 B-Cell Non-Hodgkin Lymphoma	National Research Center for Hematology, Russia	P1/2	CCC (50)
Mb-Cart20.1 B-Cell Non-Hodgkin Lymphoma	Miltenyi Biomedicine GmbH	P1/2	CCC (50)
Shr-A1912 B-Cell Non-Hodgkin Lymphoma	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1/2	CCC (50)
Sscart-19 B-Cell Non-Hodgkin Lymphoma	Shanghai Tongji Hospital, Tongji University School of Medicine	P1/2	CCC (50)
Allo-501A B-Cell Non-Hodgkin Lymphoma	Allogene Therapeutics	P1/2	CCC (48)
Allo-647 B-Cell Non-Hodgkin Lymphoma	Allogene Therapeutics	P1/2	CCC (48)
Carcik-Cd19 B-Cell Non-Hodgkin Lymphoma	Fondazione Matilde Tettamanti Menotti De Marchi Onlus	P1/2	CCC (48)
Clls52 B-Cell Non-Hodgkin Lymphoma	Cellectis S.A.	P1/2	CCC (48)
ctx131 B-Cell Non-Hodgkin Lymphoma	CRISPR Therapeutics	P1/2	CCC (48)
Dualcar-Nk19/70 Cell B-Cell Non-Hodgkin Lymphoma	Aibin Liang，MD，Ph.D.	P1/2	CCC (48)
eb103 B-Cell Non-Hodgkin Lymphoma	Estrella Biopharma, Inc.	P1/2	CCC (48)
ex103 B-Cell Non-Hodgkin Lymphoma	Guangzhou Excelmab Inc.	P1/2	CCC (48)
Glpg5101 B-Cell Non-Hodgkin Lymphoma	Lakefront Biotherapeutics NV	P1/2	CCC (48)
Iberdomide B-Cell Non-Hodgkin Lymphoma	Celgene	P1/2	CCC (48)
Kite-363 B-Cell Non-Hodgkin Lymphoma	Kite, A Gilead Company	P1/2	CCC (48)
Kite-753 B-Cell Non-Hodgkin Lymphoma	Kite, A Gilead Company	P1/2	CCC (48)
Onc-Plureceptor Nk Cells B-Cell Non-Hodgkin Lymphoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
Ublituximab B-Cell Non-Hodgkin Lymphoma	Yazeed Sawalha	P1/2	CCC (48)
Ucart20X22 B-Cell Non-Hodgkin Lymphoma	Cellectis S.A.	P1/2	CCC (48)
4SCAR20/22/70 B-Cell Non-Hodgkin Lymphoma	Shenzhen Geno-Immune Medical Institute	P1/2	CC (47)
Allogeneic Cd19-Star T Cell B-Cell Non-Hodgkin Lymphoma	Chinese PLA General Hospital	P1/2	CC (47)
Allogenic Cd19-Car-Γδt Cell B-Cell Non-Hodgkin Lymphoma	Chinese PLA General Hospital	P1/2	CC (47)
Anti-Cd19/20-Car Vector-Transduced T Cells B-Cell Non-Hodgkin Lymphoma	Shenzhen University General Hospital	P1/2	CC (47)
Autologous Bcma/Cd19 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Bcma/Cd38 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Bcma/Gprc5D Dual-Target Car-T B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Cd19/Cd20 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Cd19/Cd22 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Cd19-Star-T Cell B-Cell Non-Hodgkin Lymphoma	Chinese PLA General Hospital	P1/2	CC (47)
Autologous Cd33/Cd123 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Cd33/Cll1 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Cd5/Cd7 Dual-Target Car-T Module B-Cell Non-Hodgkin Lymphoma	Beijing Biotech	P1/2	CC (47)
Autologous Nk Cell B-Cell Non-Hodgkin Lymphoma	Xiangyang No.1 People's Hospital	P1/2	CC (47)
cd19-cd34t metabolically programmed car transduced t-cells B-Cell Non-Hodgkin Lymphoma	Medical University of South Carolina	P1/2	CC (47)
Disialoganglioside Gd-2 B-Cell Non-Hodgkin Lymphoma	Shenzhen Geno-Immune Medical Institute	P1/2	CC (47)
Interferon ?1 (Human Fibroblast Protein Moiety) B-Cell Non-Hodgkin Lymphoma	Fred Hutchinson Cancer Center	P1/2	CC (47)
mb-106 B-Cell Non-Hodgkin Lymphoma	Mustang Bio	P1/2	CC (47)
Psma/13 B-Cell Non-Hodgkin Lymphoma	Shenzhen Geno-Immune Medical Institute	P1/2	CC (47)
Therapeutic 4Scar19 Cells B-Cell Non-Hodgkin Lymphoma	Shenzhen Geno-Immune Medical Institute	P1/2	CC (47)
Alisertib B-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P1	CC (46)
C-Car066 B-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P1	CC (46)
ft522 B-Cell Non-Hodgkin Lymphoma	Fate Therapeutics	P1	CC (46)
Hmpl-760 B-Cell Non-Hodgkin Lymphoma	Hutchmed	P1	CC (46)
Mb-Cart2019.1 B-Cell Non-Hodgkin Lymphoma	Miltenyi Biomedicine GmbH	P1	CC (46)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P2	CC (45)
at101 B-Cell Non-Hodgkin Lymphoma	AbClon	P1/2	CC (45)
azd4512 B-Cell Non-Hodgkin Lymphoma	AstraZeneca	P1/2	CC (45)
car19tif cells B-Cell Non-Hodgkin Lymphoma	Chinese PLA General Hospital	P1/2	CC (45)
cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells B-Cell Non-Hodgkin Lymphoma	University of Colorado, Denver	P1/2	CC (45)

Showing 101 to 150 of 306 assets

PreviousPage 3 of 7Next